Patents Assigned to GENRIX (SHANGHAI) BIOPHARMACERTICAL CO., LTD.
  • Epidermal growth factor receptor antibody
    Patent number: 9644031
    Abstract: Provided are an improved EGFR antibody or a functional segment thereof, comprising an engineered heavy chain and light chain. Specifically, the antibody is an engineered whole human-source monoclonal antibody. Also provided is a method for manufacturing said whole human-source antibody and usage of the antibody in the manufacture of medicines used for the treatment of tumors.
    Type: Grant
    Filed: October 6, 2015
    Date of Patent: May 9, 2017
    Assignees: GENRIX (SHANGHAI) BIOPHARMACERTICAL CO., LTD., BIOEX THERAPEUTICS INC.
    Inventors: Jie Liu, Zhuobing Zhang, Jikuan Shan, Wei Suo
  • EPIDERMAL GROWTH FACTOR RECEPTOR ANTIBODY
    Publication number: 20160017045
    Abstract: Provided are an improved EGFR antibody or a functional segment thereof, comprising an engineered heavy chain and light chain. Specifically, the antibody is an engineered whole human-source monoclonal antibody. Also provided is a method for manufacturing said whole human-source antibody and usage of the antibody in the manufacture of medicines used for the treatment of tumors.
    Type: Application
    Filed: October 6, 2015
    Publication date: January 21, 2016
    Applicants: BIOEX THERAPEUTICS INC., GENRIX (SHANGHAI) BIOPHARMACERTICAL CO., LTD.
    Inventors: Jie LIU, Zhuobing ZHANG, Jikuan SHAN, Wei SUO